Carrie Wang

Dr. Carrie Wang, an experienced surgeon and pharmacologist, has over 25 years’ experience in the development of medical products and combination products with preclinical and early clinical stage companies. She directed in vivo studies at Kardium as well as studies at Angiotech that led to the development of the drug eluting Taxus® stents and was project leader for the development of 5-FU coated central venous catheters at Angiotech.

At Xphase Pharmaceuticals, Inc. and PacGen Biopharmaceuticals, Corp. she directed due diligence activities and evaluated merger and acquisition opportunities, adding to her more than 10 years of experience in business development. Dr. Wang has 12 years clinical experience (as attending surgeon) in general and laparoscopic surgery and was one of the first laparoscopic surgeons in Sichuan province.